Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Peter Heutink
Based on 36 articles published since 2008
||||
Expertise Level
The expertise of Peter Heutink ranks in the
  • Top 2.2%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 36 articles on the topic.
Graphical view (beta)
Uncounted papers?
Aliases Heutink, P   ·   Heutink, Peter
Work Locations
Details
Most likely:    University of Tubingen      
2017
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston TX USA. · Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston TX USA. · German Center for Neurodegenerative Diseases (DZNE) and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam 1081HZ, The Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. · Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, The Netherlands. · Department of Neurology, Erasmus MC, Rotterdam, The Netherlands. · Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Pubmed 29140481
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA. · University California Irvine, Irvine, CA, USA. · Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, Wales, UK. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Reta Lila Weston Institute, University College London, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. Electronic address: · Pubmed 28867149
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Graduate School of Cellular & Molecular Neuroscience, Tübingen, 72074, Germany. · European Research Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, Groningen, 9700AD, The Netherlands. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, IL, USA. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Medical & Molecular Genetics, King's College London, London, UK. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., N.1150, Houston, TX, 77030, USA. · German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 28137300
2016
  • Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey. Electronic address: · Dept. of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department Molecular Biology and Genetics, Neurodegeneration Research Laboratory, Bogazici University, 34342, Istanbul, Turkey. · Institute for Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey. · Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey. · Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey; Dept. of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Pubmed 26972524
2015
  • Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, German Center for Neurodegenerative diseases (DZNE)-Tübingen, Tübingen, Germany. Electronic address: · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative diseases (DZNE)-Tübingen, Tübingen, Germany. · Pubmed 26260214
  • Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Epidemiology and Biostatistics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Center for Neurogenomics and Cognitive Research, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · Pubmed 26087293
2014
  • 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK2 IRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience - Department of Pathophysiology and Transplantation, "Dino Ferrari" Centre, Università degli Studi di Milano, 20149 Milan, Italy. · 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy. · 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany. · 8 UCL Genetics Institute, London WC1E 6BT, UK. · 9 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK. · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK10 Neurology Clinic, Attiko Hospital, University of Athens, 126 42 Haidari, Athens, Greece11 Neurology Clinic, Philipps University, 35032 Marburg, Germany. · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK. · 13 Division of Inborn Errors of Metabolism, University Children's Hospital Heidelberg, 69120 Heidelberg, Germany. · 14 Institut of Human Genetics, Julius-Maximilian-University, 97070 Würzburg, Germany. · 6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany. · 7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany. · 4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy. · 15 Department of Nuclear Medicine, University Hospital, 97080 Würzburg, Germany. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK. · 16 Department of Nuclear Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy. · 12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK. · 17 Serviço de Neurologia, Hospital Beatriz Ângelo, 2674-514 Loures, Portugal. · 18 Movement Disorder Unit, CHU Grenoble, Joseph Fourier University, and INSERM U836, Grenoble Institute Neuroscience, F-38043 Grenoble, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France20 Centre d'Investigation Clinique (CIC-9503), Département de Neurologie, Hôpital Pitié-Salpétriêre, AP-HP, Paris, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France21 Département de Génétique et Cytogénétique, Pitié-Salpêtrière hospital, 75013 Paris, France. · 22 DZNE-Deutsches Zentrum für Neurodegenerative Erkrankungen (German Centre for Neurodegenerative Diseases), Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany. · 23 Department of Clinical Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. · 24 Department of Neurology and Neurosurgery, University of Tartu, 50090 Tartu, Estonia. · 25 Department of Pathophysiology, Centre of Excellence for Translational Medicine, University of Tartu, 50411 Tartu, Estonia. · 26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK · Pubmed 24993959
2012
  • Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, Tübingen, Germany. · Pubmed 22777693
Probable:    Vrije Universiteit Amsterdam      
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Graduate School of Cellular & Molecular Neuroscience, Tübingen, 72074, Germany. · European Research Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, Groningen, 9700AD, The Netherlands. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, IL, USA. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Medical & Molecular Genetics, King's College London, London, UK. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., N.1150, Houston, TX, 77030, USA. · German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 28137300
2016
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, United Kingdom. · INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Epinière, ICM, France. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, The Netherlands. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom; UCL Genetics Institute, London, United Kingdom. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom. · Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France; Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds, United Kingdom. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom. Electronic address: · Pubmed 27640074
2015
  • Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Epidemiology and Biostatistics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Center for Neurogenomics and Cognitive Research, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · Pubmed 26087293
2014
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Section Stochastics, Department of Mathematics, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands. · 1] Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands. · Pubmed 23736218
2012
  • Section of Medical Genomics, Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 22427796
2011
  • Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 21248740
2009
  • Section of Medical Genomics, Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 18973254
Probable:    Miscellaneous institutions in Tubingen      
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. · The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. · Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. · Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. · Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. · German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. · Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. · Harvard Stem Cell Institute, Cambridge, MA 02138, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 28860381
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Clinical Genetics, VU University Medical Center (VUmc), Amsterdam, The Netherlands. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China. · School of Pharmacy, University of Reading, Whiteknights, Reading, UK. · Centre for Integrated Neuroscience and Neurodynamics, University of Reading, Whiteknights, Reading, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Division of Medicine, University College London, London, UK and 15UCL Genetics Institute, Department of Genetics, Environment and Evolution, University College London, London, UK. · Pubmed 27798102
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK; Medical Genetics and Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK; Department of Regional Neurosciences, Royal Victoria Hospital, Belfast, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, Forvie Site, University of Cambridge, Cambridge, UK. · Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Genome Biology of Neurodegenerative Diseases, Tübingen, Germany. · Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Center for Scientific Research (CNRS), and Research Unit UMR_S 1127 at Pierre and Marie Curie University University of Paris VI at Sorbonne Universités, Institut du Cerveau et de la Moelle épinière Brain and Spine Institute (ICM), Paris, France; Clinical Investigation Center Unit 1422 at INSERM and AP-HP Hôpital de la Pitié Salpêtrière, Centre d'Investigation Clinique Pitié Neurosciences, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, UK. · Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. · Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · UCL Genetics Institute, London, UK. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. Electronic address: · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. Electronic address: · Pubmed 27017469
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Center for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, United Kingdom. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany and Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Reta Lila Weston Institute, University College London Institute of Neurology, London, United Kingdom. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · UCL Genetics Institute, University College London, London, United Kingdom. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD. · Pubmed 26389967
2015
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Radiology, University of California, San Diego, La Jolla, CA, USA. · Department of Cognitive Science, University of California, San Diego, La Jolla, CA, USA. · Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA. · NORMENT; Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tubingen, Tubingen, Germany. · Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. · Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Wales, UK. · The John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL, USA. · Department of Neurology, Taub Institute on Alzheimer's Disease and the Aging Brain, and Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA. · Department of Molecular Physiology and Biophysics, Vanderbilt Center for Human Genetics Research, Vanderbilt University, Nashville, TN, USA. · Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Biostatistics, and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA, USA. · Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Paul-Ehrlich-Straße 15, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Sorbonne Université, UPMC Univ Paris 06, Paris, France. · UCL Genetics Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · INSERM UMR1043, CPTP, CHU Purpan, Toulouse, France. · Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA. · The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA. · Deparment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands. · Deparment of Internal Medicine, University of Washington, Seattle, WA, USA. · Icelandic Heart Association, Kopavogur, Iceland. · Department of Epidemiology, University of Washington, Seattle, WA, USA. · Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Washington, DC, USA. · Department of Neurology, Boston University School of Medicine, Boston, MA, USA. · Norwegian Centre for Dementia Research, Department of Old Age Psychiatry, Oslo University Hospital, Oslo, Norway. · Department of Geriatric Psychiatry, Akershus University Hospital, Oslo, Norway. · Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Alzheimer's Disease Research Centre, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden. · Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Neurology, Akershus University Hospital, Oslo, Norway. · Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Department of Geriatric Medicine, University Hospital Reykjavik, Reykjavik, Iceland. · deCODE Genetics/Amgen, Reykjavik, Iceland. · Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Pubmed 25687773
2014
  • 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2]. · 1] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. [2]. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. · 23andMe, Inc., Mountain View, California, USA. · 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2] Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · 1] Department of Biostatistics, University of Washington, Seattle, Washington, USA. [2] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [3] Paul Sabatier University, Toulouse, France. · 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. [2] Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. [3] National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Massachusetts, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · 1] Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. [2] Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. · deCODE Genetics, Reykjavík, Iceland. · Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. · The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · 1] Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [2] Department of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [3] Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. · Stanford Prevention Research Center, Stanford University, Stanford, California, USA. · Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. · Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. · 1] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [2] Paul Sabatier University, Toulouse, France. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. [4] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. [2] Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA. [3] Department of Neurology, Columbia University Medical Center, New York, New York, USA. [4] Department of Psychiatry, Columbia University Medical Center, New York, New York, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Neuroscience Center, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA. · 1] Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. [2] Department of Neurology, Papageorgiou Hospital, Thessaloniki, Greece. · Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. · 1] Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. [2] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle, North Carolina, USA. · New York State Department of Health Wadsworth Center, Albany, New York, USA. · 1] Sorbonne Université, UPMC Université Paris 06, UM 75, INSERM U1127, Institut du Cerveau et de la Moelle, Paris, France. [2] CNRS, UMR 7225, Paris, France. [3] Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France. · Department of Human Genetics, University of Miami School of Medicine, Miami, Florida, USA. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Pubmed 25064009
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 36 total) written by Peter Heutink about Parkinson Disease:

  • Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease. 2017
  • Establishing the role of rare coding variants in known Parkinson's disease risk loci. 2017
  • β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease. 2017
  • Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts. 2017
  • Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. 2017
  • Discovery and functional prioritization of Parkinson's disease candidate genes from large-scale whole exome sequencing. 2017
  • Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance. 2016
  • Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's. 2016
  • Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease. 2016
  • Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data. 2016
Show List of Full Article Records
Google Searches

Learn more about Peter Heutink using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Tubingen
Vrije Universiteit Amsterdam
Miscellaneous institutions in Tubingen
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Tubingen
2017
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston TX USA. · Jan and Dan Duncan Neurologic Research Institute, Texas Children's Hospital, Houston TX USA. · German Center for Neurodegenerative Diseases (DZNE) and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam 1081HZ, The Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. · Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, The Netherlands. · Department of Neurology, Erasmus MC, Rotterdam, The Netherlands. · Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Pubmed 29140481
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; Data Tecnica International, Glen Echo, MD, USA. · University California Irvine, Irvine, CA, USA. · Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands. · Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; Netherlands Consortium for Healthy Ageing (NCHA), Rotterdam, the Netherlands; Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands. · MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, Wales, UK. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Reta Lila Weston Institute, University College London, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. Electronic address: · Pubmed 28867149
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Graduate School of Cellular & Molecular Neuroscience, Tübingen, 72074, Germany. · European Research Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, Groningen, 9700AD, The Netherlands. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, IL, USA. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Medical & Molecular Genetics, King's College London, London, UK. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., N.1150, Houston, TX, 77030, USA. · German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 28137300
2016
  • Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey. Electronic address: · Dept. of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department Molecular Biology and Genetics, Neurodegeneration Research Laboratory, Bogazici University, 34342, Istanbul, Turkey. · Institute for Experimental Medicine, Genetics Department, Istanbul University, Istanbul, Turkey. · Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey. · Istanbul University, Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Capa, 34390 Istanbul, Turkey; Dept. of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Pubmed 26972524
2015
  • Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, German Center for Neurodegenerative diseases (DZNE)-Tübingen, Tübingen, Germany. Electronic address: · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative diseases (DZNE)-Tübingen, Tübingen, Germany. · Pubmed 26260214
  • Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Epidemiology and Biostatistics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Center for Neurogenomics and Cognitive Research, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · Pubmed 26087293
2014
  • 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK2 IRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience - Department of Pathophysiology and Transplantation, "Dino Ferrari" Centre, Università degli Studi di Milano, 20149 Milan, Italy. · 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy. · 3 Department of Neurology, University Hospital, 97080 Würzburg, Germany. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany. · 8 UCL Genetics Institute, London WC1E 6BT, UK. · 9 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK. · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK10 Neurology Clinic, Attiko Hospital, University of Athens, 126 42 Haidari, Athens, Greece11 Neurology Clinic, Philipps University, 35032 Marburg, Germany. · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK. · 13 Division of Inborn Errors of Metabolism, University Children's Hospital Heidelberg, 69120 Heidelberg, Germany. · 14 Institut of Human Genetics, Julius-Maximilian-University, 97070 Würzburg, Germany. · 6 Department of Neurology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany. · 7 Department of Paediatric and Adult Movement Disorders and Neuropsychiatry, Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany. · 4 Parkinson Institute, Istituti Clinici di Perfezionamento, 20126 Milan, Italy. · 15 Department of Nuclear Medicine, University Hospital, 97080 Würzburg, Germany. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK. · 16 Department of Nuclear Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milano, Italy. · 12 Reta Lila Weston Institute of Neurological Studies, UCL Institute of Neurology, London WC1N 3BG, UK. · 17 Serviço de Neurologia, Hospital Beatriz Ângelo, 2674-514 Loures, Portugal. · 18 Movement Disorder Unit, CHU Grenoble, Joseph Fourier University, and INSERM U836, Grenoble Institute Neuroscience, F-38043 Grenoble, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France20 Centre d'Investigation Clinique (CIC-9503), Département de Neurologie, Hôpital Pitié-Salpétriêre, AP-HP, Paris, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France. · 19 Université Pierre et Marie Curie-Paris6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975; Inserm, U975, Cnrs, UMR 7225, Paris, France21 Département de Génétique et Cytogénétique, Pitié-Salpêtrière hospital, 75013 Paris, France. · 22 DZNE-Deutsches Zentrum für Neurodegenerative Erkrankungen (German Centre for Neurodegenerative Diseases), Hertie Institute for Clinical Brain Research, University of Tübingen, 72076 Tübingen, Germany. · 23 Department of Clinical Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK. · 24 Department of Neurology and Neurosurgery, University of Tartu, 50090 Tartu, Estonia. · 25 Department of Pathophysiology, Centre of Excellence for Translational Medicine, University of Tartu, 50411 Tartu, Estonia. · 26 Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA. · 5 Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1N 3BG, UK · 1 Department of Molecular Neuroscience, UCL Institute of Neurology, London WC1N 3BG, UK · Pubmed 24993959
2012
  • Center for Bioinformatics Tuebingen (ZBIT), University of Tuebingen, Tübingen, Germany. · Pubmed 22777693
Vrije Universiteit Amsterdam
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Université Pierre et Marie Curie Paris 06 UMR S 1127, Sorbonne Université, Institut du Cerveau et de la Moelle Epinière, Paris, France; U 1127 and Centre d'Investigation Clinique 1422, Institut National de Santé et en Recherche Médicale, Paris, France; U 7225, Centre National de Recherche Scientifique, Paris, France; Département de Neurologie et de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France. · Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. · San Francisco Veterans Affairs Medical Center and Department of Neurology, UCSF School of Medicine, San Francisco, CA, USA. · Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, ON, Canada. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, University Paris-Sud, UMRS 1018, Villejuif, France. · Voyager Therapeutics, Cambridge, MA, USA. · Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC, USA. · Department of Neurology, Leiden University Medical Center, Leiden, Netherlands. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program of Harvard Medical School and Brigham and Women's Hospital, Boston, MA, USA; Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA; Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA, USA. Electronic address: · Pubmed 28629879
  • Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo2Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo5Multimodal Imaging Laboratory, University of California at San Diego, La Jolla. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla6Department of Radiology and Biomedical Imaging, University of California, San Francisco. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland. · German Center for Neurodegenerative Diseases (DZNE), Tübingen. · Department of Psychiatry, University of California at San Diego, La Jolla9Department of Psychiatry, University of Copenhagen, Copenhagen, Denmark. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo10Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla12Sciences Graduate Program, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla. · Norwegian Centre for Mental Disorders Research (NORMENT), K. G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo. · Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany. · Department of Medical Genetics, University of Oslo, Oslo, Norway11Department of Medical Genetics, Oslo University Hospital, Oslo, Norway15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway17Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla15K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway. · K. G. Jebsen Inflammation Research Centre, Research Institute of Internal Medicine, Oslo, Norway16Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital Rikshospitalet, Oslo, Norway18Division of Gastroenterology, Institute of Medicine, University of Bergen, Bergen, Norway19Norwegian Primary Sclerosing Cholangitis (PSC) Research Center, Department of Transplantation Medicine, Oslo. · Sorbonne Universités, Université Pierre-et-Marie Curie (UPMC) Paris 06, UM 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France21Institut National de la Santé et de la Récherche Médicale (INSERM), Unité 1127, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France22Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France23Institut du Cerveau et de la Moelle Epinière (ICM), Paris, France24Assistance Publique-Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Clinical Neuroscience, National Hospital for Neurology and Neurosurgery (NHNN), University College London, London, England. · Department of Molecular Neurosciences, Institute of Neurology, University College London, London, England. · Department of Clinical Genetics, Vrije Universiteit (VU) University Medical Center, Amsterdam, the Netherlands4German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Rita Lila Weston Institute, University College London, London, England. · Multimodal Imaging Laboratory, University of California at San Diego, La Jolla8Department of Psychiatry, University of California at San Diego, La Jolla13Department of Neurosciences, University of California at San Diego, La Jolla29Department of Radiology, University of California at San Diego, La Jolla. · German Center for Neurodegenerative Diseases (DZNE), Tübingen27Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany30Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Pubmed 28586827
  • German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Graduate School of Cellular & Molecular Neuroscience, Tübingen, 72074, Germany. · European Research Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, Groningen, 9700AD, The Netherlands. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, IL, USA. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Medical & Molecular Genetics, King's College London, London, UK. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., N.1150, Houston, TX, 77030, USA. · German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 28137300
2016
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, United Kingdom. · INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Epinière, ICM, France. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. · Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, The Netherlands. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom; UCL Genetics Institute, London, United Kingdom. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom. · Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom. · Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. · INSERM, UMR 946, Genetic Variation and Human Diseases Unit, Paris, France; Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne, Paris, France. · Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds, United Kingdom. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, United Kingdom. Electronic address: · Pubmed 27640074
2015
  • Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Anatomy and Neurosciences, section Quantitative Morphology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Epidemiology and Biostatistics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Center for Neurogenomics and Cognitive Research, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Pathology, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands. · Department of Medical genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands; German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · Pubmed 26087293
2014
  • Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Section Stochastics, Department of Mathematics, Faculty of Sciences, Vrije Universiteit, Amsterdam, The Netherlands. · 1] Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands [2] Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands. · Pubmed 23736218
2012
  • Section of Medical Genomics, Department of Clinical Genetics, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 22427796
2011
  • Department of Clinical Genetics, Section of Medical Genomics, VU University Medical Centre, Amsterdam, The Netherlands. · Pubmed 21248740
2009
  • Section of Medical Genomics, Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. · Pubmed 18973254
Miscellaneous institutions in Tubingen
2017
  • Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. · The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway. · Brain and Mind Research Institute, Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada. · The Parkinson's Institute and Clinical Center, Sunnyvale, CA 94085, USA. · Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · Department of Pharmacology, University of California at Davis, Davis, CA 95616, USA. · Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA. · Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway. · German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany. · Harvard NeuroDiscovery Center, Harvard Medical School, Boston, MA 02115, USA. · Harvard Stem Cell Institute, Cambridge, MA 02138, USA. · Neurogenomics Laboratory and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. · Pubmed 28860381
2016
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Psychological Medicine and Neurology, Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · Department of Clinical Genetics, VU University Medical Center (VUmc), Amsterdam, The Netherlands. · German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Division of Life Science, Hong Kong University of Science and Technology, Hong Kong SAR, People's Republic of China. · School of Pharmacy, University of Reading, Whiteknights, Reading, UK. · Centre for Integrated Neuroscience and Neurodynamics, University of Reading, Whiteknights, Reading, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany. · Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Division of Medicine, University College London, London, UK and 15UCL Genetics Institute, Department of Genetics, Environment and Evolution, University College London, London, UK. · Pubmed 27798102
  • Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham & Women's Hospital, Cambridge, MA. · Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA. · Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA. · Department of Neurology, Brigham and Women's Hospital, Boston, MA. · Department of Neurology, Massachusetts General Hospital, Boston, MA. · Department of Medical Genomics, VU University Medical Center, Neuroscience Campus Amsterdam, Amsterdam, HZ, The Netherlands. · German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany. · John Van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY. · INSERM, Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of ageing and age related diseases, Villejuif, France. · University Paris-Sud, UMRS 1018, Villejuif, France. · Sorbonne Université, Université Pierre et Marie Curie Paris 06 UMR S 1127, Institut National de Santé et en Recherche Médicale U 1127 and Centre d'Investigation Clinique 1422, Centre National de Recherche Scientifique U 7225, Institut du Cerveau et de la Moelle Epinière, Assistance Publique Hôpitaux de Paris, Département de Neurologie et de Génétique, Hôpital Pitié-Salpêtrière, Paris, France. · Voyager Therapeutics, Clinical Development, Cambridge, MA. · Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands. · Pubmed 27717005
  • Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Division of Life Science, Hong Kong University of Science and Technology, Hong Kong Special Administrative Region, China. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Genetics and Epigenetics of Neurodegeneration, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; Genetics and Epigenetics of Neurodegeneration, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK; Medical Genetics and Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK; Department of Regional Neurosciences, Royal Victoria Hospital, Belfast, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK; Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, Forvie Site, University of Cambridge, Cambridge, UK. · Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, Netherlands. · Genome Biology of Neurodegenerative Diseases, Tübingen, Germany. · Research Unit U1127 at INSERM, Research Unit UMR 7225 at the French National Center for Scientific Research (CNRS), and Research Unit UMR_S 1127 at Pierre and Marie Curie University University of Paris VI at Sorbonne Universités, Institut du Cerveau et de la Moelle épinière Brain and Spine Institute (ICM), Paris, France; Clinical Investigation Center Unit 1422 at INSERM and AP-HP Hôpital de la Pitié Salpêtrière, Centre d'Investigation Clinique Pitié Neurosciences, Paris, France. · Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research (HIH), Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Department of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Sobell Department of Motor Neuroscience, UCL Institute of Neurology, London, UK. · Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. · School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. · Department of Clinical Neurosciences, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK. · Reta Lila Weston Institute for Neurological Studies, UCL Institute of Neurology, London, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · UCL Genetics Institute, London, UK. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, Cardiff, UK. Electronic address: · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. Electronic address: · Pubmed 27017469
  • Department of Clinical Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council Center for Neuropsychiatric Genetics and Genomics, Department of Psychological Medicine and Neurology, Cardiff University School of Medicine, Cardiff, United Kingdom. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, F-75013, Paris, France. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany and Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, United Kingdom. · Reta Lila Weston Institute, University College London Institute of Neurology, London, United Kingdom. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · UCL Genetics Institute, University College London, London, United Kingdom. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD. · Pubmed 26389967
2015
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Radiology, University of California, San Diego, La Jolla, CA, USA. · Department of Cognitive Science, University of California, San Diego, La Jolla, CA, USA. · Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA. · NORMENT; Institute of Clinical Medicine, University of Oslo and Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research University of Tubingen, Tubingen, Germany. · Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. · Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA. · Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University School of Medicine, Wales, UK. · The John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL, USA. · Department of Neurology, Taub Institute on Alzheimer's Disease and the Aging Brain, and Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA. · Department of Molecular Physiology and Biophysics, Vanderbilt Center for Human Genetics Research, Vanderbilt University, Nashville, TN, USA. · Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Biostatistics, and Epidemiology, Boston University Schools of Medicine and Public Health, Boston, MA, USA. · Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · German Center for Neurodegenerative Diseases (DZNE)-Tübingen, Paul-Ehrlich-Straße 15, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Sorbonne Université, UPMC Univ Paris 06, Paris, France. · UCL Genetics Institute and Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · INSERM UMR1043, CPTP, CHU Purpan, Toulouse, France. · Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA. · The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA. · Deparment of Epidemiology, Erasmus MC University Medical Center, Rotterdam, Netherlands. · Deparment of Internal Medicine, University of Washington, Seattle, WA, USA. · Icelandic Heart Association, Kopavogur, Iceland. · Department of Epidemiology, University of Washington, Seattle, WA, USA. · Laboratory of Epidemiology, Demography and Biometry, Intramural Research Program, National Institute on Aging, Washington, DC, USA. · Department of Neurology, Boston University School of Medicine, Boston, MA, USA. · Norwegian Centre for Dementia Research, Department of Old Age Psychiatry, Oslo University Hospital, Oslo, Norway. · Department of Geriatric Psychiatry, Akershus University Hospital, Oslo, Norway. · Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway. · Alzheimer's Disease Research Centre, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden. · Institute of Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Neurology, Akershus University Hospital, Oslo, Norway. · Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. · Department of Geriatric Medicine, University Hospital Reykjavik, Reykjavik, Iceland. · deCODE Genetics/Amgen, Reykjavik, Iceland. · Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Pubmed 25687773
2014
  • 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2]. · 1] Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. [2]. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] Department of Neurology, Focus Program Translational Neuroscience, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. · 23andMe, Inc., Mountain View, California, USA. · 1] Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. [2] Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · 1] Department of Biostatistics, University of Washington, Seattle, Washington, USA. [2] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [3] Paul Sabatier University, Toulouse, France. · 1] Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. [2] Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA. [3] National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Massachusetts, USA. · Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. · 1] Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. [2] Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA. · deCODE Genetics, Reykjavík, Iceland. · Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. · The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · 1] Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [2] Department of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. [3] Department of Neurology, Erasmus MC University Medical Center, Rotterdam, the Netherlands. · Stanford Prevention Research Center, Stanford University, Stanford, California, USA. · Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. · Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. · 1] INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France. [2] Paul Sabatier University, Toulouse, France. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA. [2] Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA. [3] Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. [4] Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, USA. · 1] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. [2] Gertrude H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA. [3] Department of Neurology, Columbia University Medical Center, New York, New York, USA. [4] Department of Psychiatry, Columbia University Medical Center, New York, New York, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Neuroscience Center, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA. · 1] Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessaly, Larissa, Greece. [2] Department of Neurology, Papageorgiou Hospital, Thessaloniki, Greece. · Department of Neurology, Boston University School of Medicine, Boston, Massachusetts, USA. · 1] Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA. [2] The Taub Institute for Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, New York, USA. · Reta Lila Weston Institute, University College London Institute of Neurology, Queen Square, London, UK. · Genome Biology for Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. · Epidemiology Branch, National Institute of Environmental Health Sciences, US National Institutes of Health, Research Triangle, North Carolina, USA. · New York State Department of Health Wadsworth Center, Albany, New York, USA. · 1] Sorbonne Université, UPMC Université Paris 06, UM 75, INSERM U1127, Institut du Cerveau et de la Moelle, Paris, France. [2] CNRS, UMR 7225, Paris, France. [3] Pitié-Salpêtrière Hospital, Department of Genetics and Cytogenetics, Paris, France. · Department of Human Genetics, University of Miami School of Medicine, Miami, Florida, USA. · 1] Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. [2] School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology and Medicine, London, UK. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA. · Pubmed 25064009
Helmholtz-Gemeinschaft
2017
  • German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Graduate School of Cellular & Molecular Neuroscience, Tübingen, 72074, Germany. · European Research Institute for the Biology of Aging, University of Groningen, University Medical Centre Groningen, Groningen, 9700AD, The Netherlands. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK. · Northwestern University Feinberg School of Medicine, Ken and Ruth Davee Department of Neurology, Chicago, IL, USA. · Inserm U1127, CNRS UMR7225, Sorbonne Universités, UPMC Univ Paris 06, UMR_S1127, Institut du Cerveau et de la Moelle épinière, Paris, France. · Institute of Psychological Medicine and Clinical Neurosciences, MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA. · Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK. · Department of Medical & Molecular Genetics, King's College London, London, UK. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Genetic Epidemiology Unit, Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. · Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA. · Department of Neurology, Baylor College of Medicine, Houston, TX, USA. · Department of Neuroscience and Program in Developmental Biology, Baylor College of Medicine, Houston, TX, USA. · Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, 1250 Moursund St., N.1150, Houston, TX, 77030, USA. · German Center for Neurodegenerative Diseases (DZNE), Otfried-Müller-Str. 23, Tübingen, 72076, Germany. · Department of Clinical Genetics, VU University Medical Center, Amsterdam, 1081HZ, The Netherlands. · Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Pubmed 28137300
10 Other Locations Show
Yearly article counts 006654453111
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.